AIMS: To evaluate the effect of T cell co-culture on mitomycin C treated and untreated Tenon's capsule fibroblasts. METHODS: IL-2 dependent allogeneic T cells were incubated over a monolayer of mitomycin C treated or control fibroblasts. Fibroblast numbers were evaluated by direct counts using phase contrast microscopy. To determine whether T cell mediated lysis was a consequence of MHC mismatch, co-culture experiments were repeated with autologous T cells. The effect of Fas receptor blockade was established by co-incubation with a Fas blocking (M3) antibody. RESULTS: T cell co-culture resulted in a dramatic reduction in fibroblast survival compared to mitomycin C treatment alone (p = 0.032). T cell killing required fibroblast/lymphocyte cell to cell contact and was observed in both allogeneic and autologous co-culture experiments. Fas blocking antibodies did not significantly inhibit T cell killing (p = 0.39). CONCLUSION: T cells augment mitomycin C treated fibroblast death in vitro. Similar mechanisms may contribute to the cytotoxic effect of mitomycin C in vivo and account for the largely hypocellular drainage blebs that are observed clinically.
AIMS: To evaluate the effect of T cell co-culture on mitomycin C treated and untreated Tenon's capsule fibroblasts. METHODS:IL-2 dependent allogeneic T cells were incubated over a monolayer of mitomycin C treated or control fibroblasts. Fibroblast numbers were evaluated by direct counts using phase contrast microscopy. To determine whether T cell mediated lysis was a consequence of MHC mismatch, co-culture experiments were repeated with autologous T cells. The effect of Fas receptor blockade was established by co-incubation with a Fas blocking (M3) antibody. RESULTS: T cell co-culture resulted in a dramatic reduction in fibroblast survival compared to mitomycin C treatment alone (p = 0.032). T cell killing required fibroblast/lymphocyte cell to cell contact and was observed in both allogeneic and autologous co-culture experiments. Fas blocking antibodies did not significantly inhibit T cell killing (p = 0.39). CONCLUSION: T cells augment mitomycin C treated fibroblast death in vitro. Similar mechanisms may contribute to the cytotoxic effect of mitomycin C in vivo and account for the largely hypocellular drainage blebs that are observed clinically.
Authors: J G Crowston; A N Akbar; P H Constable; N L Occleston; J T Daniels; P T Khaw Journal: Invest Ophthalmol Vis Sci Date: 1998-02 Impact factor: 4.799
Authors: Jonathan G Crowston; Lydia H Chang; Peter H Constable; Julie T Daniels; Arne N Akbar; Peng T Khaw Journal: Invest Ophthalmol Vis Sci Date: 2002-03 Impact factor: 4.799
Authors: Frank Bochmann; Claude Kaufmann; Christoph N Becht; Ivo Guber; Michael Kaiser; Lucas M Bachmann; Michael A Thiel Journal: BMC Ophthalmol Date: 2011-01-17 Impact factor: 2.209
Authors: E A B F Lima; N Ghousifam; A Ozkan; J T Oden; A Shahmoradi; M N Rylander; B Wohlmuth; T E Yankeelov Journal: Sci Rep Date: 2018-09-28 Impact factor: 4.379
Authors: Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus Journal: Adv Ther Date: 2019-03-11 Impact factor: 3.845